.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
The All India Institute of Medical Sciences (AIIMS) and the Indian Space Research Organisation (ISRO) recently signed a landmark agreement to advance space medicine research. This collaboration marks a significant milestone for India’s human spaceflight ambitions. By joining forces, these premier institutions aim to explore how the human body responds to the harsh conditions of space. Consequently, this partnership will create a robust framework for both ground-based and space-based studies.
India is currently pushing boundaries in human spaceflight, which necessitates deeper medical insights. The Human Space Flight Centre (HSFC) and AIIMS will focus on human physiology and cardiovascular regulation. Additionally, they will study musculoskeletal health in microgravity conditions. These areas are critical for ensuring the safety and well-being of astronauts during missions like Gaganyaan.
Interestingly, the insights gained from space studies have profound implications for patients on Earth. Prof K K Deepak, former head of physiology at AIIMS, explained that microgravity induces changes resembling accelerated aging. For instance, astronauts experience significant muscle loss and bone weakening. Therefore, studying these processes helps scientists better understand geriatric conditions.
Furthermore, technologies like leg blood flow devices can treat circulatory problems in the general population. AIIMS Director Prof M Srinivas highlighted that this MoU provides the \"escape velocity\" for medical innovation. He noted that the research would benefit the nation and humankind. ISRO Chairman V. Narayanan also emphasized the importance of such partnerships. Ultimately, this collaboration strengthens India's biomedical research capabilities significantly.
Q1: What are the primary focus areas of the AIIMS-ISRO collaboration?
The partnership focuses on human physiology, cardiovascular regulation, musculoskeletal health in microgravity, and genomics. It also addresses microbiome research and behavioral health for astronauts.
Q2: How does space medicine research benefit patients on Earth?
It provides insights into accelerated aging processes, such as bone density loss and muscle atrophy. This knowledge helps doctors develop better treatments for osteoporosis and circulatory disorders.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
AIIMS and ISRO signed a landmark MoU to collaborate on space medicine research, exploring human physiology in space to enhance medical treatments on Earth....
6 months ago
Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today
